Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
(MTR) O/S 1.8 M -PE 7 next ACY ..next low float nuclear BOMB
(MTR) O/S 1.8 M -PE 7 next ACY ..next low float nuclear BOMB
BFI like buying MCdonalds at $1 ..BIF new listed company with massive upside potential
(SNPX) MC 9 M-O/S 5 M-ALZHEIMER P2b Data Soon ,Price $1.80 already up 50 cents since my last recommendation and this one has potential to move north $20 dollars
(SNPX) MC 9 M-O/S 5 M-ALZHEIMER P2b Data Soon ,Price $1.80 already up 50 cents since my last recommendation and this one has potential to move north $20 dollars
(SNPX) MC $7 M-O/S 5 M-ALZHEIMER PHASE 2b Data soon / NEW listed stock =LIFETIME OPP
https://www.otcmarkets.com/stock/SNPX/profile
(LOAC) MC 29 M -FLOAT 440K --UNKNOWN Covid gem
"4D pharma is at a pivotal time of its growth and development. It is developing an extensive pipeline with multiple Live Biotherapeutic drug candidates in the clinic and has presented world-first proof of concept data in multiple indications. 4D pharma’s clinical programmes are targeting cancer, including a clinical collaboration with Merck & Co., respiratory diseases including COVID-19 and asthma, gastrointestinal diseases, and pre-clinical programmes targeting neurological diseases such as Parkinson’s disease, and autoimmune diseases; in addition, the Company has a research collaboration with MSD (Merck & Co.) in the field of vaccines."
https://www.microbiometimes.com/4d-pharma-plc-announces-merger-with-longevity-a-special-purpose-acquisition-company-spac-and-its-intention-to-gain-a-nasdaq-listing/
LOAC next BRPA ..MCap 29 million Shares Out 2.6 mil
"4D pharma is at a pivotal time of its growth and development. It is developing an extensive pipeline with multiple Live Biotherapeutic drug candidates in the clinic and has presented world-first proof of concept data in multiple indications. 4D pharma’s clinical programmes are targeting cancer, including a clinical collaboration with Merck & Co., respiratory diseases including COVID-19 and asthma, gastrointestinal diseases, and pre-clinical programmes targeting neurological diseases such as Parkinson’s disease, and autoimmune diseases; in addition, the Company has a research collaboration with MSD (Merck & Co.) in the field of vaccines."
https://www.microbiometimes.com/4d-pharma-plc-announces-merger-with-longevity-a-special-purpose-acquisition-company-spac-and-its-intention-to-gain-a-nasdaq-listing/
LOAC next BRPA also a covid 19 play and has only 440k shares on the float ...MEGA OPP
SNPX =MC $6 M-ALZHEIMER PHASE 2 Data soon--Shares Out 5 Million /trading under cash of $8 million / a NEW spin-off which begun trading a few days ago = A LIFETIME OPP stock guys...
https://www.otcmarkets.com/stock/SNPX/profile
ACER =MC $33 M--GREAT News out
Acer Therapeutics Announces Full Enrollment of Pivotal Bioequivalence Trial of ACER-001 for Urea Cycle Disorders
https://finance.yahoo.com/news/acer-therapeutics-announces-full-enrollment-133000257.html
Topline trial results expected in Q1 2021; targeting a pre-NDA meeting with FDA in Q2 2021
i know final results will take some time but according to management there will be trial updates from time to time and the first one will be soon . Whatever any good news like partnership(s) or positive clnical trial update and this ultra low floater will explode like a nuclear bomb ,valuation of 7 million is more than a PURE GIFT
SNPX =MC $6 M-ALZHEIMER PHASE 2 Data soon--Shares Out 5 Million /trading under cash of $8 million / a NEW spin-off which begun trading a few days ago = A LIFETIME OPP stock guys...
https://www.otcmarkets.com/stock/SNPX/profile
SNPX =MC $6 M-ALZHEIMER PHASE 2 Data soon--Shares Out 5 Million /trading under cash of $8 million / a NEW spin-off which begun trading a few days ago = A LIFETIME OPP stock guys...
https://www.otcmarkets.com/stock/SNPX/profile
SNPX =MC $6 M-ALZHEIMER PHASE 2 Data soon--O/S 5 Million /trading under cash of $8 million / a NEW spin-off which begun trading a few days ago = A LIFETIME OPP stock guys...
https://www.otcmarkets.com/stock/SNPX/profile
SNPX =MC $6 M-ALZHEIMER PHASE 2 Data soon--O/S 5 Million /trading under cash of $8 million / a NEW spin-off which begun trading a few days ago = A LIFETIME OPP stock guys...
https://www.otcmarkets.com/stock/SNPX/profile
SNPX= NEW Alzheimer Stock trading at laughable $25 million valuation a low floater with Phase 2 trial in Alzheimer a $10+ BILLION Market .Company is a new spinoff and just begins to trade on Nasdaq in last days so its still UNKNOWN
HCDI EXPLODINGGGGG told ya
HCDI =MC $26 M-Float 2 M--Profitable next Q --NEW Nasdaq stock = could run to $15-20
HCDI =MC $26 M-Float 2 M--Profitable next Q --NEW Nasdaq stock = could run to $15-20
CYTH exploding next ist ACER
CYTH EXPLODINGGGGGGGGGGGGGG...Market cap only $15 million trading at cash and they have a Blockbuster in Phase 3
ETTX =TRADING AT CASH and has 2 BLOCKBUSTERS in PHASE 3 =RALLYYYY next 10 Bagger
ADTX =MC $25 M--COVID EUA APPROVAL IMMINENT , they expect to launch the Product in January so approval should come in the coming days. this low float stock could run to $10 on approval
"AditxtScore™ for COVID-19, for use in detecting antibodies against SARS-CoV-2 antigens, and for which we are awaiting a response from the U.S. Food and Drug Administration regarding the Emergency Use Authorization (EUA) application that we filed in August. As we’ve announced, we’re working hard to position the Company for commercialization of this product."
"AditxtScore’s™ operations will initially be co-located at the facilities of Salveo Diagnostics, Inc., the Company’s collaboration partner, located in Richmond, VA. This will expedite the commercial launch of AditxtScore™ for COVID-19, which is targeted for January 2021."
https://finance.yahoo.com/news/aditxt-secures-clia-certification-aditxtscore-133000460.html
ADTX =COVID EUA APPROVAL IMMINENT ..stock about to EXPLODEEE